Skip to main content
Log in

Therapie eines malignen sympathischen Paraganglioms des Zuckerkandl'schen Organs — ein Fallbericht

Therapy of a malignant sympathetic paraganglioma of the organ of Zuckerkandl — A case report

  • Kasulstilken
  • Published:
Klinische Wochenschrift Aims and scope Submit manuscript

Summary

We present a case report on a 35-year-old patient in whom a malignant sympathetic paraganglioma of the organ of Zuckerkandl was the cause of severe hypertension with excessive perspiration at night. Since curative surgery was not possible medical treatment was initiated. Interferon alfa 2b (Intron A, Essex Pharma) and the somatostatin-analogue SMS 201–995 (Sandostatin, Sandoz) had no effect on catecholamine production and progression of the tumor. Treatment with alpha-methyl-para-tyrosin (MPT, [Metyrosin], Demser, MSD) turned out to be an effective and well tolerable therapy in this patient with peritoneal carcinosis. Clinical and hormonal progression of the paraganglioma resumed only after two years of therapy, which constitutes the longest documented period of time of successful MPT treatment. The superior efficacy of MPT in our patient should encourage postoperative medical treatment with MPT in malignant pheochromocytoma or malignant paraganglioma, particularly when the tumor turns out to be resistent to alpha blocking drugs.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Abbreviations

BKS:

Blutkörperchensenkungsgeschwindigkeit

DOPA:

3,4-Dihydroxyphenylalanin gamma

GT:

Gamma-Glutamyl-Transferase

GOT:

Glutamat-Oxalazetat-Transaminase

GPT:

Glutamat-Pyruvat-Transaminase

Gy:

Gray-Einheit

HPLC:

Hochdruck-Flüssigkeits-Chromatographie

IU:

International Units

J-MIBG:

Jodmetajodobenzylguanidin

MPT:

alpha-methyl-para-tyrosin (Metyrosin)

PTH:

Parathormon

SMS:

Somatostatin

TT3:

gesamtes Trijodthyronin

TT4:

gesamtes Tetrajodthyronin (Thyroxin)

TBG:

Thyroxin-bindendes Globulin

TSH:

Thyreoidea-Stimulierendes-Hormon

Literatur

  1. Averbuch ASD, Steakley CS, Young RC, Gelmann EP, Goldstein DS, Stull R, Keiser HR (1988) Malignant pheochromocytoma: effective treatment with a combination of cyclophosphamide, vincristine and dacarbazine. Ann Intern Med 109:267–273

    Google Scholar 

  2. Brogden RN, Heel RC, Speight TM, Avery GS (1981) Alpha-methyl-para-tyrosine: A review of its pharmacology and clinical use. Drugs 21:81–89

    Google Scholar 

  3. Chevinsky AH, Minton JP, Falko JM (1990) Metastatic pheochromocytoma associated with multiple endocrine neoplasia syndrome type II. Arch Surg 125:935–938

    Google Scholar 

  4. Eriksson B, öberg K, Alm G, Karlsson A, Lundquist G, Magnusson A, Wide L, Wilander E (1987) Treatment of malignant endocrine pancreatic tumors with human leukocyte interferon. Cancer Treat Rep 71 (1):31–37

    Google Scholar 

  5. Fischer M (1987) Stellenwert des MIBG in der Diagnostik und Therapie chromaffiner Tumoren. In: Engelhardt D, Mann K (Hrsg) Endokrin-aktive maligne Tumoren, 1. Aufl. Springer, Berlin Heidelberg New York, S 124–131

    Google Scholar 

  6. Hauptmann JB, Modlinger RS, Ertel NH (1983) Pheochromocytoma resistent to alpha-adrenergic blockade. Arch Intern Med 143:2321–2323

    Google Scholar 

  7. Imperato-McGinley J, Gautier T, Ehlers K, Zullo MA, Goldstein DS, Vaughan ED (1987) Reversibility of catecholamine-induced dilated cardiomyopathy in a child with a pheochromocytoma. N Engl J Med 13:793–797

    Google Scholar 

  8. Kuchel O, Buu NT, Edwards DJ (1990) Alternative catecholamine pathways after tyrosine hydroxylase inhibition in malignant pheochromocytoma. J Lab Clin Med 115:449–453

    Google Scholar 

  9. Landsberg L, Young JB (1985) Catecholamines and the adrenal medulla. In: Wilson JD, Foster DW (eds) Williams Textbook of Endocrinology, 7th edn. Saunders, Philadelphia, pp 891–965

    Google Scholar 

  10. Löhrs U (1987) Morphologische und immunhistochemische Befunde bei malignen endokrinen Tumoren. In: Engelhardt D, Mann K (Hrsg) Endokrin-aktive maligne Tumoren, 1. Aufl. Springer, Berlin Heidelberg New York, S 1–10

    Google Scholar 

  11. Manger WM, Gifford RW (1977) Pheochromocytoma. Springer, Berlin Heidelberg New York

    Google Scholar 

  12. Moertel CG, Rubin J, Kvols LK (1989) Therapy of metastatic carcinoid tumor and the malignant carcinoid syndrome with recombinant leukocyte A interferon. J Clin Oncol 7:865–868

    Google Scholar 

  13. Saller B, Jacob K, Markl A, Zwiebel FM, Engelhardt D, Mann K (1989) Rezidivierende Hochdruckkrisen und Dyspnoe nach einseitiger Adrenalektomie wegen Phäochromozytom bei einer 44jährigen Patientin. Der Internist 31:78–81

    Google Scholar 

  14. Schmoll HJ, Peters HD, Fink U (1987) Phäochromozytom. Kompendium internistische Onkologie. Springer, Berlin Heidelberg New York, S 865–871

    Google Scholar 

  15. Schöber C, Schuppert F, Schmoll E, Stahl M, Poliwoda H, Wilke H, Schmoll HJ (1989) Interferon alpha 2b in patients with advanced neuroendocrine gut tumors. Molecular Biotherapy 1 [Suppl] abstract 100

  16. Schuppert F, Schöber C, Schmoll E, Stahl M, Poliwoda H, Wilke H, Schmoll HJ, von zur Mühlen A (1990) Interferon alpha 2b in patients with neuroendocrine gut tumors (carcinoids) and endocrine pancreatic tumors (EPT). Acta Endocrinologica 122 (1):45, abstract 89

    Google Scholar 

  17. Schürmeyer TH, Dralle H, Schuppert F, von zur Mühlen A (1988) Präoperative Diagnostik bei Verdacht auf Phäochromozytom-retrospektive Beurteilung diagnostischer Kriterien. Acta Med Austriaca 4:106

    Google Scholar 

  18. Serri O, Comtois R, Bettez P, Dubuc P, Buu NT, Kuchel O (1984) Reduction in the size of a pheochromocytoma pulmonary metastasis by metyrosine therapy. N Engl J Med 310:1264–1265

    Google Scholar 

  19. Sheps SG, Jiang N-S, Klee GG, Van Heerden JA (1990) Recent developments in the diagnosis and treatment of pheochromocytoma. Mayo Clin Proc 65:88–95

    Google Scholar 

  20. Sisson J, Frager MS, Valk TW, Gross MD, Swanson DP, Wieland DM, Tobes MC, Beierwalter WH, Thompson NW (1981) Scintigraphic localization of pheochromocytoma. N Engl J Med 305:12–17

    Google Scholar 

  21. Tippett PA, McEwan AJ, Ackery DM (1986) A re-evaluation of dopamine excretion in pheochromocytoma. Clin Endocrinol 25:401–410

    Google Scholar 

  22. Trautmann ME, Neuhaus C, Willemer S, Hügens-Penzel M, Koop H, Schwerk WB, Arnold R (1990) Hormone secretion and growth of endocrine gastrointestinal tumors during treatment with a somatostatin-analogue. Acta Endocrinologica 122 (1):23, abstract 45

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Schuppert, F., Scheumann, G.F.W., Schöber, C. et al. Therapie eines malignen sympathischen Paraganglioms des Zuckerkandl'schen Organs — ein Fallbericht. Klin Wochenschr 69, 937–942 (1991). https://doi.org/10.1007/BF01798547

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01798547

Key words

Navigation